Whole Exome Sequencing analysis of Archival …• Utility of FFPE samples for Whole Exome...
Transcript of Whole Exome Sequencing analysis of Archival …• Utility of FFPE samples for Whole Exome...
Whole Exome Sequencing analysis of Archival Formalin
Fixed Paraffin Embedded Tissue (FFPE): comparison of
different library preparation methods
Prashant K. Singh, PhD Assistant Director, Genomics Shared Resource
Roswell Park Comprehensive Cancer Center
Disclosure
I have no relevant financial or nonfinancial
relationships in the products or services described,
reviewed, evaluated or compared in this
presentation.
Outline
• Introduction
• Challenges with FFPE samples
• Different methods for NGS library prep
• Study design
• Results
Sample Procurement for Cancer research
Source: https://www.umassmed.edu/ccoe/core-services/tissue-and-tumor-bank/procurement-methods/
Formalin-Fixed, Paraffin-Embedded tissue
• FFPE procurement is the standard for tumor banking and
remains part of clinical standard of care.
• The tissue is preserved in formaldehyde, also known as formalin,
to preserve the proteins and vital structures within the tissue.
• Why FFPE?
– preserves the morphology and cellular details
– easier to cut slices of required sizes
– immunostaining and morphology
– tissue microarray
– long-term storage at ambient temperature
FFPE- Opportunities and Challenges
• These samples are an invaluable resource for clinical research.
• Characterized histological and pathological annotation combined
with extensive clinical data.
• Allow retrospective studies
– increase in number of samples
– follow up clinical data- disease outcome, treatment response and
survival
• Enables laser-capture microdissection (LCM) of specific cells or
tumor compartment to understand tumor heterogeneity and
microenvironment using NGS approaches
FFPE- Opportunities and Challenges
• Enables quantitative pathology and spatially profiling to detect multiple
biomarkers using multispectral imaging (e.g. Vectra), Mass cytometry
(e.g. Imaging Mass Cytometry) and NanoString-DSP
• Can be used with various imaging and genomic application
NanoString- DSP
FFPE- Opportunities and Challenges
• Formaldehyde, creates reversible cross-links between intracellular
macromolecules such as protein and DNA
• Crosslinks include protein–protein, protein–DNA, and DNA–formaldehyde
adducts and interstrand DNA crosslinks
• Crosslinking of DNA bases with nearby histones results in a conformational
change of DNA
• Formaldehyde-induced crosslinks of DNA reduce the stability of double-
stranded DNA
• Extensive cross-linking of proteins with nucleic acids, which leads to
fragmentation of DNA and RNA
FFPE- Opportunities and Challenges
• Major Factors contributing to DNA/RNA fragmentation:
– types of paraffin
– pre-fixation treatment
– fixation delay (i.e. perioperative ischemic time),
– the fixation process
– tissue preparation
– archival storage (age of FFPE)
FFPE- Challenges in NGS applications
• FFPE DNA has great potential for NGS analyses
• Targeted DNA sequencing to screen known actionable mutations in
FFPE samples have been successfully used
• The use of DNA extracted from FFPE for whole exome sequencing
(WES) is presently limited
– Unpredictable library prep
– Small insert sizes
– Low and/or uneven coverage
– High PCR duplicates
– Spurious variant calling
FFPE- Challenges in quality of RNA/DNA
FFPE RNA FFPE DNA
Hedegaard et al., PLoS One. 2014; 9(5):e98187
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project. Genet Med. 2018 Feb 1. doi: 10.1038/gim.2017.241
FFPE- Challenges in NGS applications
FFPE samples presented a lower proportion of
regions reaching the targeted depth of 70X (0.351
versus 0.782) for the FF samples (Figure 1a)
The median standard deviation was between 1.1
and 5.8X higher in FFPE than matching FF
(p < 2.2e−16) meaning sequencing coverage was
less uniform in FFPE data.
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-
embedded specimens: pilot study for the 100,000 Genomes Project.
Genet Med. 2018 Feb 1. doi: 10.1038/gim.2017.241
FFPE- Challenges in NGS applications
High FF–FFPE agreement was detected in
reliable regions whereas the agreement was
lower in regions of low complexity.
• Coverage depth was non-uniform, alignment metrics were suboptimal for FFPE data.
• High discrepancy between these data sets was dependent on the analytical tool set employed.
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project. Genet Med. 2018 Feb 1. doi: 10.1038/gim.2017.241
Scope of Present Study
• Utility of FFPE samples for Whole Exome Sequencing (WES).
• The pre-capture PCR step within the hybridization-based target
enrichment protocol is a critical and can significantly affect the quality
of sequencing data and downstream analysis.
• To increase efficacy of template production we tested several different
methods to add adaptors (pre-capture PCR) within the WES protocol.
Study Design
• Samples: 2 patients derived FFPE (4 samples total)
• Pre-Capture PCR using 6 different library prep methods
• Target enrichment with Agilent SureSelect Human All Exon V6.
Basic workflow for NGS library preparation
Biotechniques. 2014 Feb 1;56(2):61-4, 66, 68, passim. doi: 10.2144/000114133. eCollection 2014.
Different adapters for NGS library prep
Results- Sample QC
• DNA extraction: Covaris truXTRAC FFPE DNA
• DNA QC
– Qubit
– TapeStation
– qPCR QC
Results- Sample QC
Sample ID Original (ng/uL)
ddCq
77-old 18.54 2.08
77-New 16.28 0.23
64-old 23.15 2.32
64-New 10.28 0.57
• New FFPE samples were of high quality compared to Old FFPE samples
• DNA was sheared with a Covaris S220 Focused-ultrasonicator
• Pre-capture libraries were prepared using Six different library preparation kits
• 100ng DNA for each sample used as input for library prep
Results- Pre-capture Library Yields
• Pre-capture PCR showed high yields for New FFPE samples for all the kits compared to old FFPE.
• SureSelect XTHS produced the highest yield.
• Swift kit showed most consistent yield for both Old and New FFPE samples.
• DNA restoration from NEB resulted in better yield compared to non-restored sample
ddCq Agilent XTHS
KAPA HyperPrep
Rubicon ThruPLEX
Swift Accel-NGS 2S Plus
NEBNext Ultra II
NEBNext Ultra II
restored
PCR cycle 12 10 12 12 10 10
77-New(FFPE1) 0.23 2580 1052 398 476 316 588
64-New(FFPE2) 0.57 1605 633 358 540 251 386
77-old(FFPE3) 2.08 762 325 161 464 189 296
64-old(FFPE4) 2.32 2100 355 139 378 278 355
Pre-capture library prep yield comparison (nanograms of DNA)
Results- % On-target
• The percentage of reads in the exome regions is a useful metric to evaluate target enrichment.
• We typically achieve a over 85% on target rate with V6 kit
• New FFPE samples showed better on target than old
FFPE samples
• SureSelect XTHS achieved 75-85% on target
• NEB kit showed higher on target after restoration.
• The Swift kit generated consistent on-target rates
from 57% to 59.4%
Average depth (X)
Results- Average Read Depth
Average read depth comparison at 100X sequencing depth (60 million reads), except where indicated
• To calculate Avg read depth all the samples were normalized to 60 million PE reads (100X)
• Significant viability between samples and kits
• New FFPE samples performed better than Old samples
• None of kits achieved expect 100X avg depth
• NEB and Agilent kits performed better.
Results- Percentage of Target Bases at 20X # Reads 1X 10X 20X 50X
FFPE1 60M 97.7% 94.6% 87.0% 51.7%
FFPE2 60M 97.3% 92.8% 85.1% 56.7%
FFPE3 60M 97.4% 92.8% 81.2% 29.5%
FFPE4 60M 97.4% 91.6% 80.3% 45.7%
FFPE1 60M 97.8% 95.3% 86.2% 40.3%
FFPE2 46.6M* 97.7% 94.2% 82.1% 28.1%
FFPE3 60M 97.4% 93.8% 82.6% 30.2%
FFPE4 60M 97.4% 87.2% 62.1% 19.7%
FFPE1 60M 97.7% 94.3% 82.4% 37.1%
FFPE2 60M 97.6% 94.3% 83.3% 33.4%
FFPE3 60M 97.2% 88.5% 65.5% 9.9%
FFPE4 60M 97.2% 83.3% 54.7% 10.6%
FFPE1 60M 97.8% 95.2% 84.9% 39.2%
FFPE2 51M* 97.7% 94.5% 82.3% 31.1%
FFPE3 45M** 97.3% 89.9% 70.5% 17.7%
FFPE4 60M 97.5% 91.1% 74.0% 28.7%
FFPE1 60M 97.2% 82.8% 62.7% 34.2%
FFPE2 60M 97.3% 88.0% 72.2% 41.4%
FFPE3 60M 96.7% 83.6% 65.4% 34.2%
FFPE4 60M 95.8% 72.2% 50.6% 27.1%
FFPE1 60M 97.1% 82.3% 63.5% 37.3%
FFPE2 60M 97.0% 83.9% 65.1% 35.5%
FFPE3 60M 96.5% 81.6% 62.3% 30.7%
FFPE4 60M 96.3% 77.3% 56.4% 31.1%
NEB-Restor
Agilent XT HS
KAPA
Rubicon
Swift
NEB
• Read depth of 20X is considered sufficient to result in a high-confidence call of the variant
• New samples performed better than old samples
• SureSelect achieved over 80% targets at 20X for all samples
• KAPA , Rubicon and Swift performed equally for New FFPE samples but Swift performed better with low quality samples (FFPE 3 and 4)
Summary
ddCq Pre-Cap
yield (ng) # Reads Avg Depth % on
Target 20X
Agilent
FFPE1 0.23 2580 60M 62 76.6 87.00%
FFPE2 0.57 1605 60M 71 84.1 85.10%
FFPE3 20.8 762 60M 39 76.1 81.20%
FFPE4 2.32 2100 60M 60 81.7 80.30%
KAPA
FFPE1 0.23 1052 60M 51 63.2 86.20%
FFPE2 0.57 633 46.6M* 41 63.2 82.10%
FFPE3 20.8 325 60M 42 61.7 82.60%
FFPE4 2.32 355 60M 34 46.1 62.10%
Rubicon
FFPE1 0.23 398 60M 49 63.3 82.40%
FFPE2 0.57 358 60M 44 54.9 83.30%
FFPE3 20.8 161 60M 28 52.2 65.50%
FFPE4 2.32 139 60M 26 47.5 54.70%
Swift
FFPE1 0.23 476 60M 51 58.9 84.90%
FFPE2 0.57 540 51M* 44 59.4 82.30%
FFPE3 20.8 464 45M** 33 58.5 70.50%
FFPE4 2.32 378 60M 42 57.0 74.00%
NEB
FFPE1 0.23 316 60M 52 63.6 62.70%
FFPE2 0.57 251 60M 65 74.2 72.20%
FFPE3 20.8 189 60M 52 69.7 65.40%
FFPE4 2.32 278 60M 43 56.9 50.60%
NEB restored
FFPE1 0.23 588 60M 60 71.2 63.50%
FFPE2 0.57 386 60M 56 67.7 65.10%
FFPE3 20.8 296 60M 46 65.1 62.30%
FFPE4 2.32 355 60M 52 66.8 56.40%
• There is significant variability among samples.
• Overall SureSelectXTHS performed better for most QC metrics.
• Swift kits produces consistent results for both new and old samples.
• DNA Restoration improved performance with NEB kit.
• Overall New FFPE samples performed better than old samples with all of the kits.
WES of Clinical sample
• Exceptional responder to Immunotherapy. • To identify neoantigens • WES on different histology from same
tumor
DNA from two different tissue blocks from same patient performed differently
Conclusions
• DNA quality of FFPE samples is critical for WES performance.
• Processing of tissue and age of FFPE affect performance.
• All 6 kits tested performed better with new samples compared to old
samples
• Overall SureSelectXTHS performed better for most QC metrics.
• Swift kits produced consistent results for both new and old samples.
• DNA Restoration improved performance with NEB kit.
Future directions
• Optimized FFPE processing
• Improve DNA/RNA extraction
• Improved library prep and hybridization
Acknowledgement
Team GSR Roswell Park Genomics Shared Resource Roswell Park Bioinfromatics Shared Resource
Agilent New England Biolabs